International Myeloma Working Group molecular classification of multiple myeloma: spotlight review, Leukemia, vol.91, issue.12, pp.2210-2231, 2009. ,
DOI : 10.1016/j.beha.2007.08.004
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value, Blood, vol.116, issue.15, pp.56-65, 2010. ,
DOI : 10.1182/blood-2010-04-279596
Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?, Blood, vol.117, issue.6, pp.2009-2020, 2011. ,
DOI : 10.1182/blood-2010-07-295105
Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation, Blood, vol.108, issue.5, pp.1724-1756, 2006. ,
DOI : 10.1182/blood-2006-03-009910
Activating mutations of N-and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group phase III trial, Blood, vol.88, issue.7, pp.2699-706, 1996. ,
Clinical and biological significance of RAS mutations in multiple myeloma, Leukemia, vol.21, issue.12, pp.2280-2284, 2008. ,
DOI : 10.1038/leu.2008.142
Promiscuous Mutations Activate the Noncanonical NF-??B Pathway in Multiple Myeloma, Cancer Cell, vol.12, issue.2, pp.131-175, 2007. ,
DOI : 10.1016/j.ccr.2007.07.003
Frequent Engagement of the Classical and Alternative NF-??B Pathways by Diverse Genetic Abnormalities in Multiple Myeloma, Cancer Cell, vol.12, issue.2, pp.115-145, 2007. ,
DOI : 10.1016/j.ccr.2007.07.004
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients, Cancer Cell, vol.9, issue.4, pp.313-338, 2006. ,
DOI : 10.1016/j.ccr.2006.03.019
Prognostic Significance of Copy-Number Alterations in Multiple Myeloma, Journal of Clinical Oncology, vol.27, issue.27, pp.4585-90, 2009. ,
DOI : 10.1200/JCO.2008.20.6136
Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data, Genome Biol, vol.3, issue.12, p.75, 2002. ,
A census of amplified and overexpressed human cancer genes, Nature Reviews Cancer, vol.68, issue.1, pp.59-64, 2010. ,
DOI : 10.1038/nrc2771
A census of human cancer genes, Nature Reviews Cancer, vol.4, issue.3, pp.177-83, 2004. ,
DOI : 10.1038/nrc1299
Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients, Blood, vol.116, issue.14, pp.2543-53, 2010. ,
DOI : 10.1182/blood-2009-12-261032
The molecular classification of multiple myeloma, Blood, vol.108, issue.6, pp.2020-2028, 2006. ,
DOI : 10.1182/blood-2005-11-013458
Molecular Pathogenesis and a Consequent Classification of Multiple Myeloma, Journal of Clinical Oncology, vol.23, issue.26, pp.6333-6341, 2005. ,
DOI : 10.1200/JCO.2005.05.021
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1, Blood, vol.109, issue.6, pp.2276-84, 2007. ,
DOI : 10.1182/blood-2006-07-038430
Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du My??lome, Journal of Clinical Oncology, vol.26, issue.29, pp.4798-805, 2008. ,
DOI : 10.1200/JCO.2007.13.8545
Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma, Blood, vol.113, issue.18, pp.4331-4371, 2009. ,
DOI : 10.1182/blood-2008-09-178350
URL : https://hal.archives-ouvertes.fr/inserm-00368414
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis, Oncogene, vol.83, issue.44, pp.3866-79, 2009. ,
DOI : 10.1182/blood.V99.5.1745
URL : https://hal.archives-ouvertes.fr/inserm-00437705
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor, Blood, vol.113, issue.19, pp.4614-4640, 2009. ,
DOI : 10.1182/blood-2008-07-170464
URL : https://hal.archives-ouvertes.fr/inserm-00367812
Dys regulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines [see comments], Blood, vol.88, pp.674-81, 1996. ,
The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts, Blood, vol.92, issue.9, pp.3025-3059, 1998. ,
Genetics and Cytogenetics of Multiple Myeloma: A Workshop Report, Cancer Research, vol.64, issue.4, pp.1546-58, 2004. ,
DOI : 10.1158/0008-5472.CAN-03-2876
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients, Annals of Hematology, vol.82, issue.10, pp.654-663, 2003. ,
DOI : 10.1007/s00277-003-0685-2
A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines, Haematologica, vol.96, issue.4, pp.574-82, 2011. ,
DOI : 10.3324/haematol.2010.033456
URL : https://hal.archives-ouvertes.fr/inserm-00550232
Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies, Blood, vol.107, issue.7, pp.2633-2641, 2006. ,
DOI : 10.1182/blood-2005-10-4084
An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma, Blood, vol.112, issue.10, pp.4235-4281, 2008. ,
DOI : 10.1182/blood-2007-10-119123
Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks, Genome Research, vol.13, issue.11 ,
DOI : 10.1101/gr.1239303
Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation, Haematologica, vol.95, issue.7, pp.1150-1157, 2010. ,
DOI : 10.3324/haematol.2009.016436
A strategy for the characterization of minute chromosome rearrangements using multiple color fluorescence in situ hybridization with chromosome-specific DNA libraries and YAC clones, Human Genetics, vol.19, issue.6, pp.527-559, 1993. ,
DOI : 10.1007/BF00420933
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics, Genes, Chromosomes and Cancer, vol.40, issue.2, pp.194-203, 2005. ,
DOI : 10.1002/gcc.20231
A New molecular classification of multiple myeloma using gene expression profiling and fluorescence in situ hybridisation as predictor for event free survival, Blood, vol.104, issue.11, p.73, 2004. ,
Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma, Leukemia, vol.19, issue.2, pp.275-283, 2005. ,
DOI : 10.1038/sj.leu.2403586
Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma, Blood, vol.92, issue.5, pp.1743-1751, 1998. ,
Multicolor Spectral Karyotyping of Human Chromosomes, Science, vol.273, issue.5274, pp.494-501, 1996. ,
DOI : 10.1126/science.273.5274.494
Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping, Blood, vol.92, issue.11, pp.4269-78, 1998. ,
Cytogenetic analysis by chromosome painting using dop-pcr amplified flow-sorted chromosomes, Genes, Chromosomes and Cancer, vol.78, issue.3, pp.257-63, 1992. ,
DOI : 10.1002/gcc.2870040311
An International System for Human Cytogenetic Nomenclature, 2005. ,
A new method for class prediction based on signed-rank algorithms applied to Affymetrix?? microarray experiments, BMC Bioinformatics, vol.9, issue.1, p.16, 2008. ,
DOI : 10.1186/1471-2105-9-16
URL : https://hal.archives-ouvertes.fr/inserm-00268075
A Meta-Analysis of Human Embryonic Stem Cells Transcriptome Integrated into a Web-Based Expression Atlas, Stem Cells, vol.22, issue.4, pp.961-73, 2007. ,
DOI : 10.1634/stemcells.2006-0352
URL : https://hal.archives-ouvertes.fr/inserm-00128925
R: A Language and Environ ment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2008. ,
Bioconductor: open software development for computational biology and bioinformatics, Genome Biology, vol.5, issue.10, p.80, 2004. ,
DOI : 10.1186/gb-2004-5-10-r80
Clonal and subclonal cytogenetic aberrations: association with D-type cyclin expression and event-free survival (EFS) in multiple myeloma (MM), Blood, vol.108, issue.11, p.982, 2006. ,
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma, Haematologica, vol.96, issue.1, pp.87-95, 2011. ,
DOI : 10.3324/haematol.2010.030296
B034 A Gene Expression???Based Proliferation Index as Independent Prognostic Factor in Multiple Myeloma, Clinical Lymphoma and Myeloma, vol.9, issue.11, p.589, 2008. ,
DOI : 10.1016/S1557-9190(11)70649-7